Agenerase (amprenavir), the fifth protease inhibitor for HIV
May 1999
Glaxo is now marketing Agenerase (amprenavir), the fifth protease inhibitor for HIV.
It will be used in combo therapy with other antiretrovirals.
The usual adult dose is 1200 mg (8 capsules) BID. It also comes in a 50 mg capsule and a liquid for kids.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber's Letter includes:
- 12 issues every year, with brief articles about new meds and guidelines
- 48+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote